Helicobacter infection alters MyD88 and Trif signalling in response to intestinal ischaemia-reperfusion

Experimental Physiology

Volumn 96, Issue 2, 2011, Pages 104-113

  Hoffman, Sara M ^a   Wang, Hua ^b   Pope, Michael R ^a   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; COMPLEMENT COMPONENT C3; DECAY ACCELERATING FACTOR; MESSENGER RNA; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; INFLAMMATION; INTESTINE ISCHEMIA; MOUSE; NONHUMAN; REPERFUSION; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 78751553594     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.055426     Document Type: Article

References (49)

1. Cao Z, Hu Y, Wu W, Ha T, Kelley J, Deng C, Chen Q, Li C, Li J & Li Y (2009). The TIR/BB-loop mimetic AS-1 protects the myocardium from ischaemia/reperfusion injury. Cardiovasc Res 84, 442-451.
2. Caty MG, Guice KS, Oldham KT, Remick DG & Kunkel SI (1990). Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 212, 694-700.
3. Cerqueira NF, Hussni CA & Yoshida WB (2005). Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras 20, 336-343.
4. Chen LW, Chang WJ, Chen PH, Liu WC & Hsu CM (2008). TLR ligand decreases mesenteric ischemia and reperfusion injury induced gut damage through TNF-α signaling. Shock 30, 563-570.
5. Chiu C-J, McArdle AH, Brown R, Scott HJ & Gurd FN (1970). Intestinal mucosal lesion in low-flow states. Arch Surg 101, 478-483.
6. Cicalese L, Caraceni P, Nalesnik MA, Borle AB & Schraut WH (1996). Oxygen free radical content and neutrophil infiltration are important determinants in mucosal injury after rat small bowel transplantation. Transplantation 62, 161-166.
7. Clark JA & Coopersmith CM (2007). Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness. Shock 28, 384-393.
8. Deitch EA (2001). Role of the gut lymphatic system in multiple organ failure. Curr Opin Crit Care 7, 92-98.
9. Eror AT, Stojadinovic A, Starnes BW, Makrides SC, Tsokos GC & Shea-Donohue T (1999). Anti-inflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin Immunol 90, 266-275.
10. Feng Y, Zhao H, Xu X, Buys ES, Raher MJ, Bopassa JC, Thibault H, Scherrer-Crosbie M, Schmidt U & Chao W (2008). Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice. Am J Physiol Heart Circ Physiol 295, H1311-H1318.
11. Feng Y, Zou L, Si R, Nagasaka Y & Chao W (2010). Bone marrow MyD88 signaling modulates neutrophil function and ischemic myocardial injury. Am J Physiol Cell Physiol 299, C760-C769.
12. Fleming SD (2006). Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 39, 379-386.
13. Fleming SD, Shea-Donohue T, Guthridge JM, Kulik L, Waldschmidt TJ, Gipson MG, Tsokos GC & Holers VM (2002). Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169, 2126-2133.
14. Foltz CJ, Fox JG, Cahill R, Murphy JC, Yan L, Shames B & Schauer DB (1998). Spontaneous inflammatory bowel disease in multiple mutant mouse lines: association with colonization by Helicobacter hepaticus. Helicobacter 3, 69-78.
15. Gao Y, Fang X, Tong Y, Liu Y & Zhang B (2009). TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed Pharmacother 63, 442-450.
16. Harkin DW, Romaschin A, Taylor SM, Rubin BB & Lindsay TF (2004). Complement C5a receptor antagonist attenuates multiple organ injury in a model of ruptured abdominal aortic aneurysm. J Vasc Surg 39, 196-206.
17. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB & Moore FD (1992). Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 149, 1723-1728.
18. Huang Y, Fan XG, Wang ZM, Zhou JH, Tian XF & Li N (2004). Identification of helicobacter species in human liver samples from patients with primary hepatocellular carcinoma. J Clin Path 57, 1273-1277.
19. Hylton DJ, Hoffman SM, Rooijen NV, Tomlinson S & Fleming SD (2010a). Macrophage produced IL-12p70 mediates hemorrhage-induced damage in a complement dependent manner. Shock, doi:.
20. Hylton DJ, Phillips LM, Hoffman SM & Fleming SD (2010b). Hemorrhage-induced intestinal damage is complement independent in Helicobacter hepaticus-infected mice. Shock 34, 467-474.
21. Kaczorowski DJ, Nakao A, Vallabhaneni R, Mollen KP, Sugimoto R, Kohmoto J, Zuckerbraun BS, McCurry KR & Billiar TR (2009). Mechanisms of Toll-like receptor 4 (TLR4)-mediated inflammation after cold ischemia/reperfusion in the heart. Transplantation 87, 1455-1463.
22. Leaphart CL & Tepas JJ 3rd (2007). The gut is a motor of organ system dysfunction. Surgery 141, 563-569.
23. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, Browder W & Williams DL (2004). Modulating Toll-like receptor mediated signaling by (1→3)-β-d-glucan rapidly induces cardioprotection. Cardiovasc Res 61, 538-547.
24. Malaty HM (2007). Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol 21, 205-214.
25. Mandell L, Moran AP, Cocchiarella A, Houghton L, Taylor N, Fox JG, Wang TC & Kurt-Jones EA (2004). Intact Gram-negative Helicobacter pylori, Helicobacter felis, and Helicobacter hepaticus bacteria activate innate immunity via Toll-like receptor 2 but not Toll-like receptor 4. Infect Immun 72, 6446-6454.
26. Marsh B, Stevens SL, Packard AE, Gopalan B, Hunter B, Leung PY, Harrington CA & Stenzel-Poore MP (2009). Systemic lipopolysaccharide protects the brain from ischemic injury by reprogramming the response of the brain to stroke: a critical role for IRF3. J Neurosci 29, 9839-9849.
27. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM & Billiar TR (2006). Emerging paradigm: toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26, 430-437.
28. Moses T, Wagner L & Fleming SD (2009). TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J Leukoc Biol 86, 971-980.
29. Obonyo M, Sabet M, Cole SP, Ebmeyer J, Uematsu S, Akira S & Guiney DG (2007). Deficiencies of myeloid differentiation factor 88, Toll-like receptor 2 (TLR2), or TLR4 produce specific defects in macrophage cytokine secretion induced by Helicobacter pylori. Infect Immun 75, 2408-2414.
30. O'Brien DP, Israel DA, Krishna U, Romero-Gallo J, Nedrud J, Medof ME, Lin F, Redline R, Lublin DM, Nowicki BJ, Franco AT, Ogden S, Williams AD, Polk DB & Peek RM Jr (2006). The role of decay-accelerating factor as a receptor for Helicobacter pylori and a mediator of gastric inflammation. J Biol Chem 281, 13317-13323.
31. O'Brien DP, Romero-Gallo J, Schneider BG, Chaturvedi R, Delgado A, Harris EJ, Krishna U, Ogden SR, Israel DA, Wilson KT & Peek RM Jr (2008). Regulation of the Helicobacter pylori cellular receptor decay-accelerating factor. J Biol Chem 283, 23922-23930.
32. Oliveira AG, Rocha GA, Rocha AMC, Sanna M das GP, Moura SB, Dani R, Marinho FP, Moreira LS, Ferrari Mde M de LA, Castro LPF & Queiroz DMM (2006). Isolation of Helicobacter pylori from the intestinal mucosa of patients with Crohn's disease. Helicobacter 11, 2-9.
33. Pope MR, Hoffman SM, Tomlinson S & Fleming SD (2010). Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol 48, 356-364.
34. Pulskens WP, Teske GJ, Butter LM, Roelofs JJ, Van Der Poll T, Florquin S & Leemans JC (2008). Toll-like receptor-4 coordinates the innate immune response of the kidney to renal ischemia/reperfusion injury. PLoS ONE 3, e3596.
35. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S & Medzhitov R (2004). Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241.
36. Sisley AC, Desai T, Harig JM & Gewertz BL (1994). Neutrophil depletion attenuates human intestinal reperfusion injury. J Surg Res 57, 192-196.
37. Solnick JV, Franceschi F, Roccarina D & Gasbarrini A (2006). Extragastric manifestations of Helicobacter pylori infection-other Helicobacter species. Helicobacter 11(Suppl 1), 46-51.
38. Souza DG, Esser D, Bradford R, Vieira AT & Teixeira MM (2005). APT070 (Mirococept), a membrane-localised complement inhibitor, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury. Br J Pharmacol 145, 1027-1034.
39. Takeishi Y & Kubota I (2009). Role of Toll-like receptor mediated signaling pathway in ischemic heart. Front Biosci 14, 2553-2558.
40. Victoni T, Coelho FR, Soares AL, de Freitas A, Secher T, Guabiraba R, Erard F, de Oliveira-Filho RM, Vargaftig BB, Lauvaux G, Kamal MA, Ryffel B, Moser R & Tavares-de-Lima W (2010). Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med Microbiol Immunol 199, 35-42.
41. Weeks C, Moratz C, Zacharia A, Stracener C, Egan R, Peckham R, Moore FD Jr & Tsokos GC (2007). Decay-accelerating factor attenuates remote ischemia-reperfusion-initiated organ damage. Clin Immunol 124, 311-327.
42. Weiser MR, Williams JP, Moore FD, Kobzik L, Ma M, Hechtman HB & Carroll MC (1996). Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement. J Exp Med 183, 2343-2348.
43. Williams JP, Pechet TT, Weiser MR, Reid R, Kobzik L, Moore FD Jr, Carroll MC & Hechtman HB (1999). Intestinal reperfusion injury is mediated by IgM and complement. J Appl Physiol 86, 938-942.
44. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF & Chadban SJ (2007). TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117, 2847-2859.
45. Yang J, Ding JW, Chen LH, Wang YL, Li S & Wu H (2008). Sequential expression of TLR4 and its effects on the myocardium of rats with myocardial ischemia-reperfusion injury. Inflammation 31, 304-312.
46. Zanotti G, Casiraghi M, Abano JB, Tatreau JR, Sevala M, Berlin H, Smyth S, Funkhouser WK, Burridge K, Randell SH & Egan TM (2009). Novel critical role of Toll-like receptor 4 in lung ischemia-reperfusion injury and edema. Am J Physiol Lung Cell Mol Physiol 297, L52-63.
47. Zhai Y, Shen XD, O'Connell R, Gao F, Lassman C, Busuttil RW, Cheng G & Kupiec-Weglinski JW (2004). TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway. J Immunol 173, 7115-7119.
48. Zhang X, Kimura Y, Fang C, Zhou L, Sfyroera G, Lambris JD, Wetsel RA, Miwa T & Song WC (2007). Regulation of Toll-like receptor-mediated inflammatory response by complement in vivo. Blood 110, 228-236.
49. Zhao A, Urban JF Jr, Anthony RM, Sun R, Stiltz J, Rooijen NV, Wynn TA, Gause WC & Shea-Donohue T (2008). Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135, 217-225.